[1] |
HAYDU J E,FERRANDO A A.Early T-cell precursor acute lymphoblastic leukaemia[J]. Curr Opin Hematol,2013,20(4):369-373.
|
[2] |
COUSTAN-SMITH E,MULLIGHAN C G,ONCIU M,et al.Early T-cell precursor leukaemia:a subtype of very high-risk acute lymphoblastic leukaemia[J]. Lancet Oncol,2009,10(2):147-156.
|
[3] |
ZHANG J,DING L,HOLMFELDT L,et al.The genetic basis of early T-cell precursor acute lymphoblastic leukaemia[J]. Nature,2012,481(7380):157-163.
|
[4] |
克晓燕,高子芬. 淋巴瘤诊疗手册[M]. 2版. 北京:人民卫生出版社,2017:100-101.
|
[5] |
MOK M M,DU L,WANG C Q,et al.RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells[J]. Gene, 2014,545(1):111-116.
|
[6] |
CHOPRA A,BAKHSHI S,PRAMANIK S K,et al.Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL[J]. Eur J Haematol,2014,92(3):211-218.
|
[7] |
NEUMANN M,COSKUN E,FRANSECKY L,et al.FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors[J]. PLoS One,2013,8(1): e53190.
|
[8] |
高举,陈晓曦. 儿童急性T淋巴细胞白血病诊治进展[J]. 中国小儿血液与肿瘤杂志,2013,18(4):148-152.
|
[9] |
INUKAI T,KIYOKAWA N,CAMPANA D,et al.Clinical significance of early T-cell precursor acute lymphoblastic leukaemia:results of the Tokyo Children's Cancer Study Group Study L99-15[J]. Br J Haematol,2012,156(3):358-365.
|
[10] |
PUI C H,MULLIGHAN C G,EVANS W E,et al.Pediatric acute lymphoblastic leukemia:where are we going and how do we get there?[J]. Blood,2012,120(6):1165-1174.
|
[11] |
中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组. 中国成人急性淋巴细胞白血病诊断与治疗指南(2016年版)[J]. 中华血液学杂志,2016,37(10):837-845.
|
[12] |
MA M,WANG X,TANG J,et al.Early T-cell precursor leukemia:a subtype of high risk childhood acute lymphoblastic leukemia[J]. Front Med,2012,6(4):416-420.
|